Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0630

-1.6%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LurkeyTurkey who wrote (11307)	5/23/2012 11:13:01 AM
From: NTTG	1 Recommendation Read Replies (1) of 13111

Interesting that the pre-ASCO run up in 2010 (the year PVCT presented data) put SP into the $1.3 - 1.5 range, in 2011 SP peaked at $1.1, and in 2012 SP is struggling to stay above $0.9. Over the same time frame therapies for melanoma became more sophisticated, aggressive and the market has become more competitive. Coverage in investor news letters is not what this company needs.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next